CLMT News and Press, Calumet Specialty Products Partners L.P.

TRUFUEL® Announces Record-Breaking Sales as Rapid Growth Continues PR Newswire INDIANAPOLIS , March 4, 2026 /PRNewswire/ -- TRUFUEL ® , an industry leader in precision-engineered fuel, has achieved the highest monthly sales volume in the company's history, eclipsing the...

2026-02-27 17:52:27 ET An earnings report that fell notably short of profitability expectations was the main factor behind Calumet (NASDAQ: CLMT) stock's double-digit decline on Friday. Clearly expressing their dissatisfaction with the oil products company's performance, they tr...

2026-02-27 17:18:23 ET More on Calumet, Inc. Calumet, Inc. (CLMT) Q4 2025 Earnings Call Transcript Calumet, Inc. 2025 Q4 - Results - Earnings Call Presentation Calumet: Specialty Products' Businesses Coming Together Financially Top Oil And Gas Refining and Ma...

2026-02-27 17:17:50 ET Calumet, Inc. (CLMT) Q4 2025 Earnings Call February 27, 2026 9:00 AM EST Company Participants John Kompa - Director of Investor Relations Louis Borgmann - President, CEO & Director David Lunin - Executive VP & CFO Bruce Fleming ...

2026-02-27 10:28:30 ET Image source: The Motley Fool. Feb. 27, 2026 at 9 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-27 07:16:35 ET More on Calumet, Inc. Calumet: Specialty Products' Businesses Coming Together Financially Calumet, Inc. (CLMT) Presents at Goldman Sachs Energy, CleanTech & Utilities Conference - Slideshow Calumet, Inc. (CLMT) Presents at 2025 Wells Fargo ...

Calumet Reports Fourth Quarter and Fiscal Year 2025 Results PR Newswire Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39 Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million $222 million of recourse debt reduction in 2025 Stro...

Sunstone Hotel Investors Inc. (SHO) is expected to report $0.18 for Q4 2025 GT Biopharma Inc. (GTBP) is expected to report $-0.22 for Q4 2025 Global Partners LP representing Limited Partner Interests (GLP) is expected to report $0.6 for Q4 2025 4D Molecular Therapeutics Inc. (FDMT) is...

Calumet Inc (CLMT) is expected to report $-0.67 for Q4 2025

2026-02-22 08:07:08 ET The last week of February brings another packed stretch of earnings, with a mix of megacap technology leaders, consumer bellwethers, energy producers, financial firms, and high-growth disruptors set to report.... Read the full article on Seeking Alpha For ...